EXPERIMENTAL SECTION

General Information
Analytical thin layer chromatography was performed using Merck aluminum sheets precoated with silica gel 60 F 254 . Column chromatography was performed on Merck silica gel 60 (40-63 µm). The microwave reactions were performed in a Biotage Initiator producing controlled irradiation at 2450 MHz with a power of 0-300 W. Reaction temperatures were determined using the built-in on-line IR-sensor. C were referenced to CHCl 3 and CDCl 3 for those samples with neat CDCl 3 as solvent, respectively. For those samples with CD 3 OD as solvent chemical shifts were referenced to CD 2 HOD ( 1 H) or CD 3 OD ( 13 C). Analytical RPHPLC-MS was performed on a Gilson HPLC system with a Finnigan AQA quadropole low-resolution mass spectrometer in positive or negative ESI mode using a Onyx Monolithic C18 4.6 x 50mm 5µm (Phenomenex) or ACT C4 4.6 x 50mm, 5µm column with MeCN in 0.05% aqueous HCOOH as mobile phase at a flow rate of 4 mL/min. Preparative RPLC-MS was performed on a Gilson HPLC system using a Zorbax SB-C8, 5 µm 21.2 × 150 mm (Agilent technologies) column, with MeCN in 0.05% aqueous HCOOH as mobile phase at a flow rate of 10-15 mL/min or with MeCN in 0.1% aqueous TFA as mobile phase at a flow rate of 5 mL/min. Analytical GC-MS was performed on a Varian Saturn 2100T equipped with a CP-Sil 8 CB Low Bleed (30 m x 0.25 mm, 0.25 μm) or with a CP-Sil 5 CB Low Bleed (30 m x 0.25 mm, 0.25 μm) using a 40-300 °C temperature gradient and EI ionization. Exact molecular masses were determined on Micromass Q-Tof2 mass spectrometer equipped with an electrospray ion source. Optical rotations were obtained on a Perkin-Elmer 241 polarimeter, specific rotations ([α] D ) are reported in deg/dm and the concentration (c) is given in g/100 mL in the specified solvent. Analytische Laboratorien, Lindlar, Germany performed elemental analyses. All protease inhibitors were >95% pure according to 1 H NMR, LC-UV (254 nm and 214 or 220 nm), and LC-MS (TIC). 4 The ionic liquid 1-butyl-3methylimidazolium tetrafluoroborate NMM N-methylmorpholine EDCI N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride TBAHS tetrabutylammonium hydrogen sulfate
Abbreviatins
Chemicals
All starting materials and reagents were commercially available and used as received.
Compounds 5b 1 and 11 2 were synthesized and characterized as previously preported.
Chemistry
General Procedure A: Dialkylation to Form 2a-d
To a solution of Lactone 1a or 1b and DMPU (2.5 equiv) in anhydrous THF was added LDA (2.05 equiv) at approximately -50 °C, then 1.05 equiv allyl bromide for 2a and 2c (or benzyl bromide for 2b and 2d) was added to the mixture after 5 min at approximately -50 °C. The solution was stirred at approximately -40 °C for 1 h. Then another 1.2 equiv LDA was added to the mixture at approximately -40 °C. After 5 minutes 1.1 equiv benzyl bromide for 2a and 2c (or allyl bromide for 2b and 2d) was added at approximately -40 °C and stirred at approximately -40 °C to -30 °C for 1 h. The temperature was allowed to slowly increase up to -20 °C. The solution was quenched with aqueous NH 4 Cl and extracted with ethyl acetate. The organic layer was dried with MgSO 4 , concentrated and the crude product was purified by silica flash chromatography using 20-35% ethyl acetate in petroleum ether as eluent to give 2a-d in 2-49% isolated yields.
(3S,4S)-3-Allyl-3-benzyl-4-hydroxydihydrofuran-2(3H)-one (2a)
Compound 2a was prepared according to general procedure A, using lactone 1a (5.00 g, 48.97 mmol), dry DMPU (15.69 g, 122.4 mmol), 100 mL dry THF, LDA (51.4 mL, 2M in hexanes), allyl bromide (6.223 g, 51.43 mmol) and followed by a second addition of 29.4 mL LDA and benzyl bromide (9.212 g, 53.87 mmol). The temperature was kept at -50 °C throughout the reaction and a mechanic stirrer was used. The crude product was purified by gradient dry column vacuum chromatography using 10-90% ethyl acetate in isohexane as eluent to give 5.62 g 2a in 49% isolated yield. 
(3R,4S)-3-Allyl-3-benzyl-4-hydroxydihydrofuran-2(3H)-one (2b)
Compound 2b was prepared according to general procedure A, using lactone 1a (1.021 g, 10.00 mmol), DMPU (3.205 g, 25.00 mmol), 50 mL dry THF, 11.4 mL LDA (11.4 mL, 1.8 M in THF), benzyl bromide (1.796 g, 10.50 mmol) and followed by a second addition of 6.67 mL LDA (1.8 M in THF) and allyl bromide (1.331 g, 11.00 mmol). The crude product was purified by silica flash chromatography using 20-35% ethyl acetate in petroleum ether as eluent to give 0.035 g 2b in about 2% isolated yield. (3R,4R)-3-Allyl-3-benzyl-4-hydroxydihydrofuran-2(3H)-one (2c) Compound 2c was prepared according to general procedure A, using lactone 1b (2.042 g, 20.00 mmol), DMPU (6.410 g, 50.00 mmol), 100 mL dry THF, LDA (22.8 mL, 1.8M in THF), allyl bromide (2.541 g, 21.00 mmol) and followed by a second addition of 13.3 mL LDA (1.8 M in THF) and benzyl bromide (3.762 g, 22.00 mmol). The crude product was purified by silica flash chromatography using 20-35% ethyl acetate in petroleum ether as eluent to give 1.532 g 2c in 33% isolated yield. (3S,4R)-3-Allyl-3-benzyl-4-hydroxydihydrofuran-2(3H)-one (2d) Compound 2d was prepared according to general procedure A, using lactone 1b (1.021 g, 10.00 mmol), DMPU (3.205 g, 25.00 mmol), 50 mL dry THF, LDA (11.4 mL, 1.8M in THF), benzyl bromide (1.796 g, 10.50 mmol) and followed by a second addition of 6.67 mL LDA (1.8 M in THF) and allyl bromide (1.331 g, 11.00 mmol). The crude product was purified by silica flash chromatography using 20-35% ethyl acetate in petroleum ether as eluent to give 0.1154 g 2d in 5% isolated yield. 
General procedure B: alternative route to 2b and 2d
The dialkylated 2a or 2c (1.0 equiv.) was oxidized to the corresponding ketone using Dess-Martin reagens (1.1 equiv) in DCM at room temperature for 1 h. The reaction mixture was extracted twice with water/DCM. The organic layers were combined and concentrated under reduce pressure. Then 30 mL THF was added to the crude followed by NaBH 4 (1.5 equiv.) and 0.3 mL methanol. The reaction mixture was stirred at room temperature for 2 h. The reaction was quenched with NH 4 Cl and extracted with DCM (3 × 30 mL). The organic layers were combined, dried with MgSO 4 and concentrated under reduced pressure. The crude product was purified by silica flash chromatography using ethyl acetate in petroleum ether as eluent to give 2d:2a (5.9:1) and 2b:2c (5.7:1) in 92% and 85% isolated yield respectively.
Compound 2b was prepared according to general procedure B, using 2c (2.152 mmol, 0.500 g), Dess-Martin reagent (2.367 mmol, 1.004 g) in DCM (40 mL). The reduction was performed using the crude ketone, NaBH 4 (3.228 mmol, 0.122 g) in THF (30 mL) and MeOH (0.3 mL). The crude product was purified by silica flash chromatography using 20-40% ethyl acetate in petroleum ether as eluent to give 0.360 g 2b and 0.063 g 2c in a 5.7:1 ratio and in 85% isolated yield (2b+2c).
Compound 2d was prepared according to general procedure B, using 2a (3.33 mmol, 0.7731 g), Dess-Martin reagent (3.66 mmol, 1.553 g) in DCM (35 mL). The reduction was performed using the crude ketone, NaBH 4 (5.000 mmol, 0.189 g) in THF (30 mL) and MeOH (0.3 mL). The crude product was purified by silica flash chromatography using 25-35% ethyl acetate in petroleum ether as eluent to give 0.608 g 2d and 0.103 g 2a in a 5.9:1 ratio and in a 92% isolated yield (2d+2a).
To a stirred solution of 1-amino-2-indanol (4.228 g, 28.34 mmol) in dry DCM (100 mL) under N 2 (g) atmosphere at 0 °C, triethylamine (11.8 mL, 85.03 mmol) was added drop-wise, subsequently followed by the drop-wise addition of TBSOTf (9.8 mL, 42.51 mmol) under vigorous stirring. The reaction was allowed to reach room temperature and was stirred for 3 h. The reaction was quenched with NH 4 Cl, diluted with 100 mL DCM and washed with 2 x 100 mL NH 4 Cl (aq. sat.). The organic phase was dried over MgSO 4 (s), concentrated and the remaining crude was purified by gradient dry column vacuum chromatography (iso-hexane:EtOAc:Et 3 N 3:1.9:0.1) to give 5.8 g of 3 in 78% isolated yield as a transparent oil. 
General procedure C: Formation of Compounds 4a-d
A 0.2-0.5 mL process vial was charged with 2a-d, 1.9-2.4 equiv 3 and 1.0 equiv [bmim]BF 4 and irradiated under microwave irradiation at 180 °C for 35 min. The reaction mixture was then dissolved in ̴ ̴ 30 mL DCM and washed with 10 mL water and 10 mL aqueous NH 4 Cl solution. The organic fraction was dried with MgSO 4 and concentrated under reduced pressure. Next, the reaction mixture was dissolved in 20-30 mL dry DCM and 8.0 S5 equiv triethylamine was added. After 5-10 min 4.0 equiv TBSOTf was added to the solution at ̴ ̴ 0 °C. The solution was stirred at room temperature overnight. If full conversion was not achieved, the solution was concentrated again and extracted with DCM/water or diethyl ether/water, more triethylamine was added followed by TBSOTf until full conversion was achieved. Then the reaction mixture was extracted with DCM/water and dried with MgSO 4 . The crude product was purified by silica flash chromatography using 5-25% ethyl acetate in petroleum ether or 0-4% methanol in DCM as eluent to give to give 50-72% isolated yields of 4a-d. 
Compound 4b was prepared according to general procedure C, using 2b (0.0500 g, 0.2152 mmol), 3 (0.1134 g 0.4304 mmol), [bmim]BF 4 (0.0520 g, 0.2301 mmol), triethylamine (0.1743 g, 1.722 mmol), TBSOTf (0.2275 g, 0.8608 mmol) and 0.12 mL dioxane as solvent. The crude product was purified by silica flash chromatography using 0-4% methanol in DCM as eluent to give 0.067 g 4b in 53% isolated yield. 
Compound 4c was prepared following general procedure C, using 2c (0.1000 g, 0.4304 mmol), 
Synthesis of the prime side scaffold
tert-Butyl 2-(propan-2-ylidene)hydrazinecarboxylate (7) To a solution of 6 (5.00 g, 37.8 mmol) in acetone (40 mL) were added MgSO 4 (1.00 g, 8.31 mmol) and AcOH (0.20 mL). The resulting mixture was refluxed at 56 °C for 1 h under nitrogen atmosphere and then cooled to 25 °C. The resulting white suspension was filtered off to remove MgSO 4 . The filter cake was washed with acetone (1 × 10 mL). The combined filtrates were concentrated under vacuum. The obtained residue was triturated with iso-hexane (2 × 10 mL) and dried under vacuum to give 6.41 g of 7 as white crystals in 98% yield. The compound was used in the next step without any additional purification. Mp: 86-87 °C. tert-Butyl 1-(4-bromobenzyl)-2-(propan-2-ylidene)hydrazinecarboxylate (8) and tert-butyl 1-(4-bromobenzyl)hydrazinecarboxylate (9) To a solution of 7 (6.41 g, 37.2 mmol) in anhydrous toluene (100 mL) were added thoroughly crushed KOH (3.13 g, 55.8 mmol) and TBAHS (1.26 g, 3.72 mmol). The reaction mixture was stirred at 50 °C for 20 min under nitrogen atmosphere after which 4-bromobenzyl bromide (11.15 g, 44.64 mmol) was added. The resulting mixture was stirred at 100 °C for 3 h. The reaction mixture was gradually cooled to 25 °C after which water (50 S7 mL) was added and the product was partitioned between the aqueous and organic layers. The aqueous layer was washed with ethyl acetate (3 × 20 mL) and the combined organic layers were washed with brine (3 × 20 mL), dried over sodium sulfate and concentrated under reduced pressure to yield crude 8 as a golden yellow oil. 
{(1S)-1-[N'-(4-Bromobenzyl)hydrazinocarbonyl]-2,2-dimethylpropyl}carbamic acid methyl ester (5a)
A 250 mL round bottom flask under nitrogen was charged with 10 (3.62 g, 13.2 mmol), 11 (1.79 g, 9.46 mmol), HOBt (1.45 g, 9.46 mmol) and anhydrous DCM (35 mL). The reaction vessel was covered with an aluminum foil, cooled to 0 °C and stirred. To this mixture NMM (4.78 g, 47.3 mmol) was added and the mixture was stirred for 30 min at 0 °C. Thereafter EDCI (2.36 g, 12.3 mmol) was added and the reaction mixture was gradually warmed to 25 °C and stirred for 15 h. Water was added to the reaction mixture and the organic layer was separated. The aqueous phase was washed with DCM (2 × 10 mL) and the combined organic layers were washed with brine (2 × 25 mL), dried over sodium sulfate and concentrated under reduced pressure. The crude product was purified by silica flash chromatography using 25-55% ethyl acetate in iso-hexane as eluent to give 2.70 g of 5a as off-white crystals in 77% isolated yield. The overall isolated yield of 5a from 6 was calculated as 61%. 
General procedure D: Formation of Compounds 12a, 12d and 13a-d
To the solution of 4a-d in THF/H 2 O (3:1) was added 0.05 equiv OsO 4 , 4.0-8.0 equiv NaIO 4 and the reaction mixture was stirred overnight at room temperature. If full conversion was not achieved, more NaIO 4 (8 equiv) was added and the reaction mixture was stirred overnight at room temperature. Next, the reaction mixture was diluted with 20 mL ethyl acetate, quenched with 15 mL NaS 2 O 3 (aq. sat.) and extracted. The aqueous layer was then extracted two more times with ethyl acetate (2 x 10 mL). The organic layers were combined and dried over MgSO 4 , concentrated and purified on silica gel with 10-35% ethyl acetate in petroleum ether to give crude aldehyde intermediates v-viii.
Bromohydrazide 5a was added to the corresponding aldehyde. Then about 15 mL dry THF was added to the mixture together with 2.0 equiv acetic acid. After 10 min stirring at room temperature 4.0 equiv Na(OAc) 3 BH was added. The mixture was stirred overnight at room temperature. The reaction was quenched with NH 4 Cl (aq. sat.), extracted with ethyl acetate (3 x 15-20 mL), dried with MgSO 4 , concentrated and purified on silica gel using 20-45 % ethyl acetate in petroleum ether as eluent to give the crude TBS-protected compound of 13a-d and products 12a and 12d.
The crude TBS-protected compound was dissolved in 1.0 mL THF and 10.0 equiv of TBAF was added to the solution which was stirred overnight. The solution was concentrated, 10-15 mL water was added and the mixture was extracted with DCM (3 x 15 mL). The combined organic layers were dried with MgSO 4 , concentrated under reduced pressure and the crude product was purified by silica flash chromatography using 4-5% methanol in DCM as eluent to give 13a-d in 34-60% isolated yields. Alcohols of 14a and 14d were obtained as side products in the syntheses of 13a and 13d respectively. 
Compound 13a was prepared following general procedure D, using 4a (0.1000 g, 0.1689 mmol), OsO 4 (0.0021 g, 0.0085 mmol), NaIO 4 (0.2892 g, 1.352 mmol) in 15 mL THF:H 2 O (3:1). A fast silica gel column was run with 10-35% ethyl acetate in petroleum ether to isolate the intermediate aldehyde [v] . Thereafter hydrazide 5a (0.0312 g, 0.0839 mmol), Na(OAc) 3 BH (0.1068 g, 0.5040 mmol) and acetic acid (0.0151 g, 0.2512 mmol) were added according to general procedure D. The crude product was purified by silica flash chromatography using 10-40 % ethyl acetate in petroleum ether as eluent to give the TBS protected compound. Deprotection was performed using TBAF (0.421 mL, 1.8 M in THF) followed by purification by silica flash chromatography using 4-5% methanol in DCM as eluent to give 0.023 g of 13a in 38% isolated yield. The crude product was purified by silica flash chromatography using 20-40 % ethyl acetate in petroleum ether as eluent to give the TBS protected compound. Deprotection was performed using TBAF (0.543 mL, 1.8 M in THF) followed by purification by silica flash chromatography using 4-5% methanol in DCM as eluent to give 0.023 g of 13b in 62% isolated yield. The crude product was purified by silica flash chromatography using 20-40 % ethyl acetate in petroleum ether as eluent to give the TBS protected compound. Deprotection was performed using TBAF (0.320 mL, 1.8 M in THF) followed by purification by silica flash chromatography using 4-5% methanol in DCM as eluent to give 0.014 g 13d in 34% isolated yield. 
Compound 14a was isolated as a side product in the first syntheses of 13a. The compound 14a was isolated by silica flash chromatography using 10-40 % ethyl acetate in petroleum ether as eluent followed by extended purification on RP-HPLC using 80-100% acetonitrile in water as eluent giving 0.0128 g 14a in 11% isolated yield calculated from 4a. 
(3R,4R)-3-Benzyl-4-((tert-butyldimethylsilyl)oxy)-1-((1S,2R)-2-((tert-butyldimethylsilyl)oxy)-2,3-dihydro-1H-inden-1-yl)-3-(2-hydroxyethyl)pyrrolidin-2-one (14d)
Compound 14d was as a side product in the first syntheses of 13d. The compound 14d was isolated by silica flash chromatography using 15-35 % ethyl acetate in petroleum ether as eluent followed by extended purification on RP-HPLC using 80-100% acetonitrile in water as eluent giving 0.048 g of 14d in 53% isolated yield calculated from 4d. 
General procedure E: Formation of compounds 13e-f
Compound 14a or 14d was oxidized using 1.2 equiv Dess-Martin reagent in 10 mL dry DCM. The mixture was stirred at room temperature for 1 h. Then another 5 mL DCM was added and the reaction was quenched with 10 mL NH 4 Cl (aq,. sat.) and 2 mL Na 2 S 2 O 3 (aq,. sat.) and extracted. The aqueous layers were extracted with DCM (2 x 15 mL), all organic layers were combined, dried with MgSO 4 and concentrated under reduced pressure. 4-(2-pyridinyl)-benzhydrazide (5b), dry THF and 2.0 equiv acetic acid were added to the mixture and stirred for 15 minutes at room temperature. Next 4.0 equiv of Na(OAc) 3 BH was added and the mixture was stirred overnight. The reaction was quenched with NH 4 Cl (aq,. sat.) and extracted with EtOAc (3 x 15 mL), dried with MgSO 4 and concentrated. The crude reaction mixture was purified by silica flash chromatography using 30-70 % ethyl acetate in petroleum ether as eluent, THF (1.0 mL) and 10.0 equiv TBAF was added and the mixture was stirred at room temperature overnight. The reaction mixture was concentrated, water was added to the mixture before it was extracted with DCM (3 x 15 mL). The organic layers were dried with MgSO 4 and concentrated under reduced pressure. The crude products were purified by silica flash chromatography using 3-5% methanol in ethyl acetate as eluent to give 13e and 13f in 48% and 38% isolated yield respectively. 
S12
Methyl ((S)-1-(2-(2-((3R
,
Methyl ((S)-1-(2-(2-((3R,4R)-3-benzyl-4-hydroxy-1-((1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-(pyridin-2-yl)benzyl)hydrazinyl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (13f)
Compound 13f was prepared according to general procedure E, using alcohol 14d (0.0480 g, 0.0805 mmol), Dess-Martin reagent (0.0410 g, 0.0966 mmol), 5b (0.030 g, 0.0810 mmol), AcOH (0.0097 mg, 0.1620 mmol), Na(OAc) 3 BH (0.0682 g, 0.3218 mmol) and 0.332 mL TBAF (1.0 M in THF). The crude product was purified by silica flash chromatography using 5% methanol in ethyl acetate as eluent to give 0.0220 g 13f in 38% isolated yield. 3 ]BF 4 (0.2 equiv), DME 0.9 mL and water 0.2 mL. The vessel was sealed under air and was irradiated with microwaves to 140 °C for 20 min. The reaction tube was thereafter allowed to reach room temperature and after adding 10 mL water the mixture was extracted with DCM (3 x 15 mL). The S13 combined organic layers were dried with MgSO 4 and concentrated under reduced pressure. Next the mixture was dissolved in 1.0 mL THF, 10 equiv TBAF (1.0 M in THF) was added and the mixture was stirred at room temperature overnight. The reaction mixture was concentrated, 10 mL water was added and then extracted with DCM (3 x 15 mL) and ethyl acetate (15 mL × 2). The combined organic layers were dried with MgSO 4 and concentrated under reduced pressure. The crude product was purified by silica flash chromatography using 4-5% methanol in DCM as eluent to give inhibitors 13g-j in 59-74% isolated yields, 19b-d in 30-45% isolated yields.
Compound 13g was prepared according to general procedure F, using 12a (0.0500 g, 0.0526 mmol), Hermann's palladacycle (0.0049 g, 0.0053 mmol), K 2 CO 3 (0.0240 g, 0.1736 mmol), 3-pyridylboronic acid (0.0214 g, 0.1741 mmol), [HP(t-Bu) 3 ]BF 4 (0.0031 g, 0.0105 mmol), DME (0.9 mL) and water (0.2 mL) followed by TBAF (0.526 mL, 1.0 M in THF). The crude product was purified by silica flash chromatography using 4-5% methanol in DCM as eluent followed by re-crystallization from DCM/diethyl ether to give 0.024 g 13g in 63% isolated yield. 
Compound 13h was prepared according to general procedure F, using 12d (0.0500 g, 0.0526 mmol), Hermann's palladacycle (0.0049 g, 0.0053 mmol), K 2 CO 3 (0.0240 g, 0.1736 mmol), 3-pyridylboronic acid (0.0214 g, 0.1714 mmol), [HP(t-Bu) 3 ]BF 4 (0.0031 g, 0.0105 mmol), DME (0.9 mL) and water (0.2 mL) followed by TBAF (0.526 mL, 1.0 M in THF). The crude product was purified by silica flash chromatography using 4-5% methanol in DCM as eluent to give 0.0222 g 13h in 59% isolated yield. , DME (0.9 mL) and water (0.2 mL) followed by TBAF (0.526 mL, 1.0 M in THF). The crude product was purified by silica flash chromatography using 4-5% methanol in DCM as eluent to give 0.028 g 13i in 74% isolated yield. 
Compound 13j was prepared according to general procedure F, using 12d (0.0500 g, 0.0526 mmol), Hermann's palladacycle (0.0049 mg, 0.0053 mmol), K 2 CO 3 (0.0240 mg, 0.1736 mmol), 3-pyridylboronic acid (0.0214 mg, 0.1741 mmol), [HP(t-Bu) 3 ]BF 4 (0.0031 mg, 0.0105 mmol), DME (0.9 mL) and water (0.2 mL). The vessel was sealed under air and irradiated with microwaves to 140 °C for 25 min. Work-up according to general procedure F followed by deprotection using TBAF (0.526 mL, 1.0 M in THF). The crude product was purified by silica flash chromatography using 4-5% methanol in DCM as eluent to give 0.0250 g 13j in 66% isolated yield. A dry 2-necked round bottom flask were charged with 4a (1.400 g, 2.364 mmol) and dry THF (23 mL). 9-BBN (10.4 mL, 5.203 mmol) was thereafter added drop wise and stirred vigorously at room temperature. The reaction was thereafter refluxed at 80 °C for 6 h. The reaction mixture was allowed to reach room temperature. A mixture of 2M NaOH (aq., 12.0 mL), H 2 O 2 (30% in water, 6.1 mL) and ethanol (4 mL) were added drop wise and the reaction mixture was stirred at room temperature for 2 h before it was diluted with EtOAc (30 mL). The organic phase was washed with NH 4 Cl (aq., sat.) (2 × 50 mL) followed by extraction of the combined aqueous phases with EtOAc (1 × 30 mL). The organic phases were dried with MgSO 4 , concentrated under reduced pressure and the crude residue was purified using gradient dry column vacuum chromatography with ethyl acetate in isohexane as eluent giving 16 in 78 % isolated yield as a transparent oil. 
A solution of 50% SO 3 Py (0.7311 g, 2.2975 mmol) in DMSO (4 mL) was slowly added to a solution of 16 (0.4670 g, 0.7656 mmol) and Et 3 N (0.54 mL, 3.828 mmol) in dry DCM (2 mL) stirred at 0 °C. The reaction mixture was allowed to reach room temperature and was stirred for 3 h. The reaction was quenched with 10 mL H 2 O and diluted with 25 mL diethyl ether. The mixture was washed with Na 2 S 2 O 3 (aq., sat.) (2 × 15 mL) and NH 4 Cl (aq., sat.) (1 × 15 mL). The aqueous phases were combined and extracted with diethyl ether (25 mL). The combined organic phases were dried with MgSO 4 and concentrated under reduced pressure. The crude mixture was diluted in toluene and concentrated under reduced pressure at 45 °C (repeated three times) to remove remaining pyridine. The crude material was transferred to round bottom flask containing 5a (0.4655 g, 0.7656 mmol), acetic acid (0.29 mL, 0.0051 mmol) in dry THF (16 mL) and with 4Å molecular sieves. The mixture was stirred at room temperature for 20 minutes before addition of Na(OAc) 3 BH (0.6490 g, 3.062 mmol). The reaction was stirred at 35 °C for 3 h. Next the mixture was quenched with 15 mL NH 4 Cl (aq., sat.) and extracted with EtOAc (3 x 15 mL). The organic phases were combined, dried with MgSO 4 and concentrated under reduced pressure. The crude mixture was purified by gradient dry column vacuum chromatography using ethyl acetate in isohexane or diethyl ether in isohexane as eluent giving 0.250 g 18 in 35% isolated yield. 5 mL) , instead of DME. The vial was sealed under air and was irradiated with microwaves to 105 °C for 1.5 h. The reaction mixture was allowed to reach room temperature and was then diluted with ethyl actetate (10 mL) and extracted with NaCl (aq. sat.) (2 × 10 mL). the organic layer was concentrated under reduced pressure and roughly purified using dry column vacuum chromatography with 0-100% ether in isohexane followed by 0-20% ethyl acetate in diethyl ether as eluents. The fractions containing the TBSprotected product were combined and concentrated under reduced pressure. The TBS-protected product was then deprotected using TBAF (0.55 mL, 1M solution in THF) in THF (2 mL). The reaction mixture was stirred at room temperature for 6 h. The reaction was quenched with NaCl (aq. sat.) and extracted with a diethyl ether:ethyl acetate mixture (70:30). The organic layer was concentrated and the crude was purified using dry column vacuum chromatography with 0-95% ethyl acetate in diethyl ether as eluent. 
Compound 19e was prepared using 18 (0.0705 g, 0.0731 mmol), 2-(tributylstannyl)-pyridyl (0.1345 g, 0.3656 mmol), Pd(PPh 3 ) 2 Cl 2 (0.0026 g, 0.0037 mmol), CuO (0.0058 g. 0.0732 mmol) in DMF (1.4 mL). The 2 mL microwave process vial was sealed under air and was irradiated with microwaves to 105 °C for 2 h. The reaction mixture was allowed to reach room temperature and was concentrated under reduced pressure. The crude mixture was first roughly purified using dry column vacuum chromatography with ether in isohexane as eluent. Next, the crude product was deprotected using 0.5 mL TBAF (1M solution in THF) in THF (4 mL) at room temperature overnight. The crude mixture was purified using dry column vacuum chromatography with 0-100% ethyl acetate in isohexane followed by 0-40% diethyl ether in ethyl acetate as eluents. Extended purification was performed on RP-HPLC using 25-80% acetonitrile in water giving 0.0115 g 19e in 16% isolated yield. 
Biological evaluation
HIV protease inhibition
The HIV-1 protease was cloned and heterologously expressed in Escherichia coli and purified as described elsewhere. 3 The K i values for the synthesized compounds were determined from two individual measurements by a fluorometric assay using the fluorescent substrate DABCYL-©-Abu-Ser-Gln-ASN-Tyr-Pro-Ile-Val-Gln-EDANS (Bachem, Bubendorf, Switzerland). 4 Measurements were performed in 96-well plates with a Fluoroskan plate reader (Labsystems, Helsinki, Finland). Excitation and emission wavelengths were 355 and 500 nm, respectively. All incubations were performed at 30 °C in 0.1 M sodium acetate-1 M NaCl-1 mM dithiothreitol (DTT)-1 mM EDTA-3% DMSO at pH 5.0 with 5 µM substrate. In order to allow substrate and inhibitor to be dissolved completely, all components (300 µL) were preincubated for at least 20 min before the reaction was started by adding enzyme. Initial rates were measured over 5 min. Data were analyzed by nonlinear regression by using SIMFIT and an equation for tightly binding inhibitors. The kinetic constants (kcat and Km) were determined by using the spectrophotometric assay with a chromophoric peptide substrate. The substrate concentration was varied over as wide a range as permitted with respect to sensitivity and soluability. The kinetic constants were estimated by nonlinear regression analysis by using SIMFIT and the equation for simple Michaelis-Menten kinetics. Assay variability was checked by inclusion of a known inhibitor and the standard deviation for the enzyme assays was ±50% of the mean.
In vitro anti-HIV activity
The in vitro anti-HIV activity was assayed in MT4 cells according to a previously published procedure 4 using the colorimetric XTT assay to monitor the cytopathogenic effects.
Determination of cytotoxicity
MT4 cells were maintained in RPMI supplemented with 10% heat inactivated fetal calf serum, penicillin (100 U/mL) and streptomycin (100 µg/mL). Briefly, compounds in serial dilutions were added to MT4 cells (2 x 10 4 cells/well) in microplates. After five days of incubation at 37 °C, the number of viable cells in each well was assessed by using a soluble formazan (XTT) assay 5 and the concentration causing 50% decrease in cell proliferation (CC 50 ) was determined.
Caco-2 cell penetration assay
The transport was measured in one direction (apical to basolateral compartment). In the assay 0.1 mL of the apical 1X HBSS buffer (pH 7.4) with a final concentration of 10 µM test compound (0.5% DMSO), was added to the apical compartment and after 60 minutes samples were withdrawn from the basolateral compartment. The basolateral buffer (0.6 mL) contained 1% BSA and 1X HBSS.
Metabolic stability
1 µM test compound was incubated with human liver microsomes (0.5 mg/ml) in phosphate buffer (100 mM, pH 7.35). After 10 min of pre-incubation at 37 °C the enzymatic reaction was initiated by addition of NADPH (1 mM final concentration) and incubated at 37 °C for 30 min. The incubations were performed in triplicates and the final concentration of solvent in the assay was 0.5% acetonitrile. The reactions were terminated by addition of an equal volume of ice-cold acetonitrile containing an internal standard and centrifuged (10 min 20000 x G, 7°). The disappearance of test compound was monitored by LC/MS/MS and the intrinsic clearance value (Cl int ) was calculated using. ‫݈ܥ‬ ௧ = ln 2 × ሾ݈݉ ݅݊ ‫‪݊ሿ‬݅ݐܾܽݑܿ݊݅‬ ‫ݐ‬ ½ × ሾ݉݃ ‫݊݅݁ݐݎ‬ ݅݊ ‫݊݅ݐܾܽݑܿ݊݅‬ , ‫ݐ‬ ½ = ln 2 ݇ 3 X-ray analysis
Inhibitors co-crystallized with HIV-1 Protease
Crystals of HIV-1 protease mutant L63P, V82T, I84V with inhibitors were produced as described before. 6 Data was collected at Maxlab, Lund, beamline I911-2 and was processed with Mosflm 7 and scaled using SCALA 8 . As a starting model for molecular replacement 1AJV was used. All structure refinement was carried out in CNS 9 and Refmac 10, 11 and model building in O 12 and Coot. 13 The final R cryst (R free ) for 13i, 19d, and 19b were 20.1% (24.5%), 23.5% (25.6%), and 22.3% (25.3%) respectively. All images were produced using a combination of O 12 and Molray. 14 S20 3. 2 Table of 
